Tetraphase Pharmaceuticals, Inc. EBITDA Margin 2013-2020 | TTPH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Tetraphase Pharmaceuticals, Inc. (TTPH) over the last 10 years. The current EBITDA margin for Tetraphase Pharmaceuticals, Inc. as of March 31, 2020 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-03-31 | $0.01B | $-0.06B | -737.50% |
| 2019-12-31 | $0.01B | $-0.07B | -942.86% |
| 2019-09-30 | $0.01B | $-0.08B | -844.44% |
| 2019-06-30 | $0.01B | $-0.08B | -1171.43% |
| 2019-03-31 | $0.02B | $-0.07B | -388.89% |
| 2018-12-31 | $0.02B | $-0.07B | -384.21% |
| 2018-09-30 | $0.02B | $-0.08B | -422.22% |
| 2018-06-30 | $0.02B | $-0.09B | -409.52% |
| 2018-03-31 | $0.01B | $-0.11B | -981.82% |
| 2017-12-31 | $0.01B | $-0.12B | -1160.00% |
| 2017-09-30 | $0.01B | $-0.11B | -1425.00% |
| 2017-06-30 | $0.01B | $-0.11B | -2100.00% |
| 2017-03-31 | $0.00B | $-0.09B | -2250.00% |
| 2016-12-31 | $0.01B | $-0.08B | -1540.00% |
| 2016-09-30 | $0.01B | $-0.07B | -1216.67% |
| 2016-06-30 | $0.01B | $-0.07B | -875.00% |
| 2016-03-31 | $0.01B | $-0.08B | -790.00% |
| 2015-12-31 | $0.01B | $-0.08B | -754.55% |
| 2015-09-30 | $0.01B | $-0.09B | -708.33% |
| 2015-06-30 | $0.01B | $-0.08B | -736.36% |
| 2015-03-31 | $0.01B | $-0.07B | -811.11% |
| 2014-12-31 | $0.01B | $-0.07B | -812.50% |
| 2014-09-30 | $0.01B | $-0.06B | -800.00% |
| 2014-06-30 | $0.01B | $-0.05B | -742.86% |
| 2014-03-31 | $0.01B | $-0.04B | -390.00% |
| 2013-12-31 | $0.01B | $-0.03B | -263.64% |
| 2013-09-30 | $0.01B | $-0.02B | -175.00% |
| 2013-06-30 | $0.01B | $-0.01B | -107.69% |
| 2013-03-31 | $0.01B | $-0.01B | -130.00% |
| 2012-12-31 | $0.01B | $-0.01B | -175.00% |
